	販売および管理費		日付
Alaunos Therapeutics	USD 447K	138K	2026-03
Amgen	USD 1.58B	354M	2026-03
AstraZeneca	USD 5.06B	455M	2026-03
Baxter International	USD 728M	33M	2026-03
Biogen	USD 554.3M	128.2M	2026-03
Bioline Rx	USD 858K	257K	2026-03
Bristol-Myers Squibb	USD 1.62B	564M	2026-03
Celltrion	KRW 12.71B	237.27B	2025-12
Corcept Therapeutics	USD 128.04M	13.3M	2026-03
Cspc Pharmaceutical	CNY 1.87B	95.62M	2025-12
Curis	USD 1.34M	3.45M	2025-12
Deva Holding AS	TRY 462.26M	48.18M	2023-09
Dianthus Therapeutics	USD 12.47M	5.89M	2026-03
Divis Laboratories Ltd	INR 3.4B	10M	2025-06
Gilead Sciences	USD 1.45B	326M	2026-03
GlaxoSmithKline	GBP 2.12B	558M	2026-03
Incyte	USD 328.1M	62.31M	2026-03
Intrexon	USD 10.31M	41K	2024-06
Ionis Pharmaceuticals	USD 151M	21M	2026-03
J&J	USD 6.03B	719M	2026-03
Kangmei Pharma	CNY 237.06M	37.35M	2026-03
Karyopharm Therapeutics	USD 9.56M	17.63M	2025-12
Knight Therapeutics	CAD 35.45M	4.43M	2025-12
Laboratorios Farma	EUR 35.32M	2.75M	2025-06
Malin Corporation	EUR 1.1M	400K	2024-12
Medical Developments International	AUD 2.84M	4.19M	2025-12
Merck	USD 2.67B	180M	2026-03
Neuren Pharmaceuticals	AUD 3.74M	2.5M	2025-12
Novartis	USD 3.14B	296M	2026-03
Organigram Holdings	CAD 22.01M	14.28M	2026-03
Ovoca Bio	EUR 632K	2.33M	2025-06
Pfizer	USD 2.92B	1.16B	2026-03
Pharma Mar	EUR 15.31M	2M	2026-03
PTC Therapeutics	USD 73.89M	13.31M	2026-03
Qiagen NV	USD 153.88M	10.77M	2025-12
Regeneron Pharmaceuticals	USD 647.7M	127.3M	2026-03
Roche Holding	CHF 7.28B	3.99B	2025-12
Sangamo BioSciences	USD 9.64M	1.83M	2024-06
Sartorius	EUR 221.3M	500K	2026-03
Sino Biopharmaceutical	CNY 7.54B	2.23B	2025-06
TG Therapeutics	USD 73.14M	22.42M	2026-03
Tilray	USD 24.85M	1.7M	2025-09
Verastem	USD 24.44M	12.17M	2025-12
Zealand Pharma A/S	91.81M	99.04M	2025-12
Zz Pientze Pharmaceu	CNY 214.31M	42.4M	2026-03